메뉴 건너뛰기




Volumn 4, Issue 2, 2007, Pages 79-82

Circulating tumor cells in the management of metastatic breast cancer patients

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CA 27-29 ANTIGEN;

EID: 34047162576     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(11)70054-7     Document Type: Article
Times cited : (12)

References (8)
  • 1
    • 4143094988 scopus 로고    scopus 로고
    • Circulating tumor cells, disease progression and survival in metastatic breast cancer
    • Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression and survival in metastatic breast cancer. N Engl J Med 2004;351:781-791.
    • (2004) N Engl J Med , vol.351 , pp. 781-791
    • Cristofanilli, M.1    Budd, G.T.2    Ellis, M.J.3
  • 2
    • 33751272999 scopus 로고    scopus 로고
    • Circulating tumor cells versus imaging - predicting overall survival in metastatic breast cancer
    • Budd GT, Cristofanilli M, Ellis MJ, et al. Circulating tumor cells versus imaging - predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006;12:6403-6409.
    • (2006) Clin Cancer Res , vol.12 , pp. 6403-6409
    • Budd, G.T.1    Cristofanilli, M.2    Ellis, M.J.3
  • 3
    • 20144385756 scopus 로고    scopus 로고
    • Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
    • Cristofanilli M, Hayes DF, Budd GT, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005;23:1420-1430.
    • (2005) J Clin Oncol , vol.23 , pp. 1420-1430
    • Cristofanilli, M.1    Hayes, D.F.2    Budd, G.T.3
  • 4
    • 33846814619 scopus 로고    scopus 로고
    • Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predicts progression-free and overall survival
    • Hayes DF, Cristofanilli M, Budd GT, et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predicts progression-free and overall survival. Clin Cancer Res 2006;12(14 pt 1):4218-4224.
    • (2006) Clin Cancer Res , vol.12 , Issue.14 PART 1 , pp. 4218-4224
    • Hayes, D.F.1    Cristofanilli, M.2    Budd, G.T.3
  • 5
    • 33745205864 scopus 로고    scopus 로고
    • Circulating tumor cells, disease progression, and survival in metastatic breast cancer
    • Cristofanilli M. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Semin Oncol 2006;33(3 suppl 9): S9-S14.
    • (2006) Semin Oncol , vol.33 , Issue.3 SUPPL. 9
    • Cristofanilli, M.1
  • 6
    • 85039220415 scopus 로고    scopus 로고
    • Stopeck A, Cristofanilli M, Budd GT, et al. Circulating tumor cells - not serum tumor markers - predict survival in metastatic breast cancer. J Clin Oncol 2006;23(16S):9516.
    • Stopeck A, Cristofanilli M, Budd GT, et al. Circulating tumor cells - not serum tumor markers - predict survival in metastatic breast cancer. J Clin Oncol 2006;23(16S):9516.
  • 7
    • 85039183957 scopus 로고    scopus 로고
    • Budd GT, Cristofanilli M, Ellis MJ, et al. Monitoring circulating tumor cells in non measurable metastatic breast cancer. J Clin Oncol 2005;23(16S):503.
    • Budd GT, Cristofanilli M, Ellis MJ, et al. Monitoring circulating tumor cells in non measurable metastatic breast cancer. J Clin Oncol 2005;23(16S):503.
  • 8
    • 85039205817 scopus 로고    scopus 로고
    • Beveridge RA, Robert NJ, Desai S, McCormack R. Early assessment of circulating tumor cell results in a community-based practice. J Clin Oncol 2005;23(16S):621.
    • Beveridge RA, Robert NJ, Desai S, McCormack R. Early assessment of circulating tumor cell results in a community-based practice. J Clin Oncol 2005;23(16S):621.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.